Luis Miguel
Antón Aparicio
Complexo Hospitalario Universitario de Santiago
Santiago de Compostela, EspañaPublicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario de Santiago (8)
2020
-
A new scenario in metastatic renal cell carcinoma: a SOG-GU consensus
Clinical and Translational Oncology, Vol. 22, Núm. 9, pp. 1565-1579
2015
-
Radium-223 dichloride: A new paradigm in the treatment of prostate cancer
Expert Review of Anticancer Therapy, Vol. 15, Núm. 3, pp. 339-348
2014
-
Cancer stem cells in genitourinary cancer
Stem Cells in Cancer: Should We Believe or Not? (Springer Netherlands), pp. 149-165
2013
-
Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor
Clinical and Translational Oncology, Vol. 15, Núm. 6, pp. 425-433
-
Erratum: Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor (Clinical and Translational Oncology DOI: 10.1007/s12094-012-0985-x)
Clinical and Translational Oncology
2012
-
Starvation profile of mTOR inhibitors
Rapamycin: Effectiveness, Safety and Drug Interactions (Nova Science Publishers, Inc.), pp. 31-52
-
Sunitinib: The first to arrive at first-line metastatic renal cell carcinoma
Advances in Therapy, Vol. 29, Núm. 3, pp. 202-217
2011
-
Expression of notch1 to -4 and their ligands in renal cell carcinoma: A tissue microarray study
Cancer Genomics and Proteomics, Vol. 8, Núm. 2, pp. 93-101